No Data
Autobio Diagnostics (603658.SH): Has repurchased a total of 1.61% of its shares.
On January 2, Gelonghui reported that Autobio Diagnostics (603658.SH) announced that as of December 31, 2024, the company had repurchased a total of 9,362,452 shares through centralized bidding trade, accounting for 1.61% of the company's total equity. The highest transaction price was 59.99 yuan/share, the lowest was 37.91 yuan/share, and the total amount paid was 436,326,014.17 yuan (excluding transaction fees).
Autobio Diagnostics Registers Several Medical Devices With National, Provincial Regulators
Autobio Diagnostics (603658.SH): The company and its wholly-owned subsidiary have obtained the medical instruments registration certificate.
On December 26, Gelonghui reported that Autobio Diagnostics (603658.SH) announced that the company and its wholly-owned subsidiary Autobio Instruments (Zhengzhou) Co., Ltd. (referred to as "Autobio Instruments") recently received the medical instruments registration certificate issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. The acquisition of this medical instruments registration certificate further enriches the company’s product menu, continuously meets market demand, serves as an effective complement to the company’s existing testing products, gradually enhances the overall competitiveness of the company’s products, and has a relatively small short-term impact on the company's operating performance.
Is Autobio Diagnostics (SHSE:603658) Using Too Much Debt?
Autobio Diagnostics' Chairman Raises Stake in Company for 21 Million Yuan
Autobio Diagnostics (603658.SH): The Chairman and actual controller, Miao Yongjun, has cumulatively completed a Shareholding of approximately 21 million yuan of the company's shares.
Gelonghui, December 12th丨Autobio Diagnostics (603658.SH) announced that as of December 12, 2024, the term of the shareholding plan implemented by Mr. Miao Yongjun, Chairman and actual controller, has expired. Mr. Miao Yongjun has cumulatively increased his shareholding in the company by 452,800 shares through the centralized bidding trading system of the Shanghai Stock Exchange, accounting for 0.0779% of the company's total share capital, with a cumulative investment amount of 21,021,355 yuan. This shareholding plan has been completed.
Earnings Not Telling The Story For Autobio Diagnostics Co., Ltd. (SHSE:603658) After Shares Rise 26%
